PRESS

3M and Zargis Announce Global Marketing Alliance


ST. PAUL, MINN. & PRINCETON, NJ (October 25, 2007) -- 3M and Zargis Medical Corp., a spin-off from Siemens Corporate Research (NYSE: SI) and a majority-owned subsidiary of Speedus Corp. (NASDAQ: SPDE) today announced an exclusive multi-year marketing agreement involving Zargis heart sound analysis software and 3M Littmann's next-generation electronic stethoscope.



Under the agreement, Zargis will support 3M in its efforts to develop a next-generation stethoscope that will be compatible with Zargis heart sound analysis software. The date on which Zargis  software will become available for use with a Littmann stethoscope has not yet been announced.



"This agreement builds on the rich Littmann brand legacy of advancing the art of auscultation,"  said Chuck Kummeth, Vice President and General Manager, 3M Medical Division.  "We are committed to bringing innovative solutions to our customers, and this agreement with Zargis will help us do this well into the future."



"We have been working closely with 3M for nearly two years to further evaluate this market and refine our product strategy," stated Zargis CEO John Kallassy.  "We believe that the use of our software could enhance the physician experience during every patient exam where a stethoscope is currently used. This alliance with 3M will allow us to seamlessly integrate our advanced sound analysis technology with 3M's next-generation electronic stethoscopes and turn this vision into a reality on a global level."



In addition, the alliance provides Zargis with a wide-range of marketing and promotional opportunities along with exclusive rights to sell its ground-breaking heart sound analysis software through the global distribution network of the Littmann brand. The agreement grants 3M a minority equity position in Zargis, following the first sale of Zargis  software through the 3M distribution channel, and a seat on Zargis board of directors.



Tom Miller, member of Siemens Medical's Executive Management Board, stated,  "We are very encouraged by this agreement and the progress Zargis has made since it spun off from Siemens Corporate Research and we look forward to continuing our support and seeing their business mature."



About 3M Health Care

3M Health Care, one of 3M's six major business segments, provides world-class innovative products and services to help health care professionals improve the practice, delivery and outcome of patient care in medical, oral care, drug delivery and health information markets.



About 3M - A Global, Diversified Technology Company

Every day, 3M people find new ways to make amazing things happen. Wherever they are, whatever they do, the company's customers know they can rely on 3M to help make their lives better. 3M's brands include Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti. Serving customers around the world, the people of 3M use their expertise, technologies and global strength to lead in major markets including consumer and office; display and graphics; electronics and telecommunications; safety, security and protection services; health care; industrial and transportation.



Littmann, Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti are trademarks of 3M. For more information, including the latest product and technology news, visitwww.3M.com.


About Zargis Medical Corp.

Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE: SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds.



About Siemens

Siemens AG (NYSE: SI - News) is one of the largest global electronics and engineering companies with reported worldwide sales of $107.4 billion in 2006. Founded 160 years ago, the company is a leader in the areas of Medical, Power, Automation and Control, Transportation, Information and Communications, Lighting, Building Technologies, Water Technologies and Services and Home Appliances. With its U.S. corporate headquarters in New York City, Siemens in the USA has sales of $21.4 billion and employs approximately 70,000 people throughout all 50 states and Puerto Rico. Eleven of Siemens' worldwide businesses are based in the United States. With its global headquarters in Munich, Siemens AG and its subsidiaries employ 480,000 people in 190 countries. For more information on Siemens in the United States:www.usa.siemens.com.


For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or phodge@zargis.com or visit the following Web sites: www.zargis.com and www.speedus.com.


# # #


Statements contained herein about Zargis that are not historical facts, including but not limited to statements about Zargis product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by Zargis, including, but not limited to, the continuing development of Zargis sales, marketing and support efforts.


 

July 30, 2010
Veterans Administration Health Care System Purchases 15 Zargis Cardioscan Systems

July 21, 2010
Zargis Awarded U.S. Army Contract

June 11, 2010
Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc. Exclusive License Agreement Allows Zargis to Expand into Respiratory Sounds Market

June 10, 2010
Zargis Medical Receives Top Honors at Medical Design Excellence Awards

May 27, 2010
Zargis Launches Telemedicine System with Real-Time Transmission of Stethoscope Sounds

May 13, 2010
U.S. Army to Showcase Zargis' Technology at Telemedicine Conference

April 20, 2010
3M Littmann Model 3200/Zargis Cardioscan Honored for Stethoscope/Software Design Innovation

April 12, 2010
Zargis Cardioscan Wins 'Best of the Best' red dot design award

September 29, 2009
Zargis Awarded Follow-On U.S. Army Contract; Mandates Expansion of Two Previous Awards

February 23, 2010
Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia

February 15, 2010
Edison Best New Product Awards Taps 3M and Zargis

January 8th, 2010
Zargis Cardioscan Cleared for Sale in Canada

December 14, 2009
Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com

December 1, 2009 - IN THE NEWS
Popular Science Magazine Innovation of the Year Issue

December 1, 2009 - IN THE NEWS
Popular Science Cardioscan Video

December 1, 2009 - IN THE NEWS
Scoping Out Stethoscopes (Contemporary Pediatrics Magazine)

November 24, 2009
Zargis Cardioscan(TM) Featured on The Early Show on CBS


November 18, 2009 - IN THE NEWS
Zargis Builds a Better Stethoscope

November 12, 2009
3M Health Care and Zargis Medical Awarded "Innovation of the Year" for Littmann(R) Model 3200 Stethoscope with Cardioscan Software

October 21, 2009
Zargis Cleared as Apple iPhone Developer; Medical Applications for Smartphones Planned

September 24, 2009
3M Global Business Manager Ingrid Blair Joins Zargis Board


September 25, 2009 - IN THE NEWS
TAMC Heart Device Approved, Deploys to Pacific Areas

September 17, 2009
Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army

August 25, 2009
Zargis Cardioscan Unveiled Through Global Marketing and Distribution Alliance With 3M Company

August 19, 2009
3M Introduces First Electronic Stethoscope with Bluetooth Wireless Capability

October 9, 2008
Zargis Receives Additional Contracts from U.S. Army

February 20, 2008
Physicians use Cardioscan to Evaluate Student Athletes during Sports Physicals

October 25, 2007
3M and Zargis Announce Global Marketing Alliance

April 18, 2007
Zargis' Cardioscan Receives Televised News Coverage

November 6, 2006
Zargis Awarded U.S. Army Contract

October 9, 2006
Study Shows Cardioscan Leads to 41% Reduction of Unnecessary and Costly Cardiac Referrals by Physicians

September 13, 2006
Study Results for Zargis Cardioscan to be Presented at American Academy of Pediatrics Conference

September 11, 2006
The Wall Street Journal Recognizes Zargis Medical With Technology Innovation Award

November 16, 2005
Panel Agrees Zargis Prototype Would Improve Referral Accuracy with Heart Murmurs

October 26, 2005
Zargis Medical Awarded Fundamental New Patent

June 30, 2005
Zargis Conducts Physician Study to Show Potential Benefits to Physicians, Insurance Companies and Patients

March 15, 2005
Zargis CTO to Speak at Medical Devices Conference

November 29, 2004
White Paper "Computer Aided Auscultation of the Heart, the Clinical Opportunity" Available at Zargis Website

November 12, 2004
Zargis Signs Exclusive Pact With Johns Hopkins University

November 5, 2004
Zargis Medical Announces the Results of a Clinical Study in Hypertrophic Cardiomyopathy (HCM)

September 14, 2004
Zargis Medical receives FDA clearance: Energy Display and Timing Annotation Added to Cardioscan

June 1, 2004
FDA Clears Zargis' Pioneering Medical Device: First Computer-Aided Device to Assist in the Detection of Heart Murmurs

April 6, 2004
Zargis Medical Updates on FDA Submission

January 12, 2004
Healthcare Veteran Joins Zargis Board

October 27, 2003
Siemens Medical Solutions Leader Joins Zargis Board

July 9, 2003
Zargis Awarded Core Patent for Acoustic Cardioscan

May 21, 2003
Zargis Medical Files with FDA for Approval of Zargis Acoustic Cardioscan System

July 15, 2002
Zargis Medical Tests New Technology, Developed at Siemens, to Improve Diagnosis of Heart Murmurs

February 20, 2002
Zargis Medical Appoints Siemens' Veteran Hejazi As President And Chief Executive Officer

March 26, 2001
Siemens' and SPEEDUS' Start-Up, Zargis Medical Corp., Announces Four Appointments to Medical Experts Board; Changes Name From Sound Diagnostics

January 16, 2001
Siemens and SPEEDUS Team Together in Start-Up to Develop Technology For Rapidly Detecting Valvular Heart Disease During Routine Patient Examinations